Journal for ImmunoTherapy of Cancer (Dec 2018)

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients

  • Iva Truxova,
  • Lenka Kasikova,
  • Michal Hensler,
  • Petr Skapa,
  • Jan Laco,
  • Ladislav Pecen,
  • Lucie Belicova,
  • Ivan Praznovec,
  • Michael J. Halaska,
  • Tomas Brtnicky,
  • Eva Salkova,
  • Lukas Rob,
  • Roman Kodet,
  • Jeremy Goc,
  • Catherine Sautes-Fridman,
  • Wolf Herman Fridman,
  • Ales Ryska,
  • Lorenzo Galluzzi,
  • Radek Spisek,
  • Jitka Fucikova

DOI
https://doi.org/10.1186/s40425-018-0446-3
Journal volume & issue
Vol. 6, no. 1
pp. 1 – 13

Abstract

Read online

Abstract A high density of tumor-infiltrating CD8+ T cells and CD20+ B cells correlates with prolonged survival in patients with a wide variety of human cancers, including high-grade serous ovarian carcinoma (HGSC). However, the potential impact of mature dendritic cells (DCs) in shaping the immune contexture of HGSC, their role in the establishment of T cell-dependent antitumor immunity, and their potential prognostic value for HGSC patients remain unclear. We harnessed immunohistochemical tests and biomolecular analyses to demonstrate that a high density of tumor-infiltrating DC-LAMP+ DCs is robustly associated with an immune contexture characterized by TH1 polarization and cytotoxic activity. We showed that both mature DCs and CD20+ B cells play a critical role in the generation of a clinically-favorable cytotoxic immune response in HGSC microenvironment. In line with this notion, robust tumor infiltration by both DC-LAMP+ DCs and CD20+ B cells was associated with most favorable overall survival in two independent cohorts of chemotherapy-naïve HGSC patients. Our findings suggest that the presence of mature, DC-LAMP+ DCs in the tumor microenvironment may represent a novel, powerful prognostic biomarker for HGSC patients that reflects the activation of clinically-relevant anticancer immunity.

Keywords